Zobrazeno 1 - 10
of 48
pro vyhledávání: '"Kumru OS"'
Autor:
Rodriguez-Aponte SA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.; The Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Naranjo CA; The Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Johnston RS; The Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Dalvie NC; The Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Crowell LE; The Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA., Bajoria S; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, Kansas, USA., Kumru OS; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, Kansas, USA., Joshi SB; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, Kansas, USA., Volkin DB; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, Kansas, USA., Love JC; The Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.; Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA.
Publikováno v:
Biotechnology and bioengineering [Biotechnol Bioeng] 2024 Aug; Vol. 121 (8), pp. 2423-2434. Date of Electronic Publication: 2023 Apr 03.
Autor:
Kumru OS; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS 66047, USA., Sanyal M; Department of Biochemistry, Stanford University School of Medicine, Palo Alto, CA 94305, USA; Sarafan ChEM-H, Stanford University, Stanford, CA 94305, USA., Friedland N; Department of Biochemistry, Stanford University School of Medicine, Palo Alto, CA 94305, USA; Sarafan ChEM-H, Stanford University, Stanford, CA 94305, USA., Hickey JM; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS 66047, USA., Joshi R; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS 66047, USA., Weidenbacher P; Department of Biochemistry, Stanford University School of Medicine, Palo Alto, CA 94305, USA; Sarafan ChEM-H, Stanford University, Stanford, CA 94305, USA., Do J; Department of Biochemistry, Stanford University School of Medicine, Palo Alto, CA 94305, USA; Sarafan ChEM-H, Stanford University, Stanford, CA 94305, USA., Cheng YC; Department of Biochemistry, Stanford University School of Medicine, Palo Alto, CA 94305, USA; Sarafan ChEM-H, Stanford University, Stanford, CA 94305, USA., Kim PS; Department of Biochemistry, Stanford University School of Medicine, Palo Alto, CA 94305, USA; Sarafan ChEM-H, Stanford University, Stanford, CA 94305, USA; Chan Zuckerberg Biohub, San Francisco, CA 94158, USA., Joshi SB; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS 66047, USA., Volkin DB; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS 66047, USA. Electronic address: volkin@ku.edu.
Publikováno v:
Vaccine [Vaccine] 2023 Oct 20; Vol. 41 (44), pp. 6502-6513. Date of Electronic Publication: 2023 Aug 22.
Autor:
Weidenbacher PA; Sarafan ChEM-H, Stanford University, Stanford, CA, USA.; Department of Chemistry, Stanford University, Stanford, CA, USA., Sanyal M; Sarafan ChEM-H, Stanford University, Stanford, CA, USA.; Department of Biochemistry, School of Medicine, Stanford University, Stanford, CA, USA., Friedland N; Sarafan ChEM-H, Stanford University, Stanford, CA, USA.; Department of Biochemistry, School of Medicine, Stanford University, Stanford, CA, USA., Tang S; Sarafan ChEM-H, Stanford University, Stanford, CA, USA.; Department of Biochemistry, School of Medicine, Stanford University, Stanford, CA, USA., Arunachalam PS; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA., Hu M; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA., Kumru OS; Vaccine Analytics and Formulation Center, Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, USA., Morris MK; California Department of Public Health, Richmond, CA, USA., Fontenot J; New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA, USA., Shirreff L; New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA, USA., Do J; Sarafan ChEM-H, Stanford University, Stanford, CA, USA.; Department of Biochemistry, School of Medicine, Stanford University, Stanford, CA, USA., Cheng YC; Sarafan ChEM-H, Stanford University, Stanford, CA, USA.; Department of Biochemistry, School of Medicine, Stanford University, Stanford, CA, USA., Vasudevan G; IAVI, New York, NY, USA., Feinberg MB; IAVI, New York, NY, USA., Villinger FJ; New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA, USA., Hanson C; California Department of Public Health, Richmond, CA, USA., Joshi SB; Vaccine Analytics and Formulation Center, Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, USA., Volkin DB; Vaccine Analytics and Formulation Center, Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, USA., Pulendran B; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA., Kim PS; Sarafan ChEM-H, Stanford University, Stanford, CA, USA. kimpeter@stanford.edu.; Department of Biochemistry, School of Medicine, Stanford University, Stanford, CA, USA. kimpeter@stanford.edu.; Chan Zuckerberg Biohub, San Francisco, CA, 94158, USA. kimpeter@stanford.edu.
Publikováno v:
Nature communications [Nat Commun] 2023 Oct 05; Vol. 14 (1), pp. 6211. Date of Electronic Publication: 2023 Oct 05.
Autor:
Kumru OS; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, USA., Bajoria S; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, USA., Kaur K; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, USA., Hickey JM; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, USA., Van Slyke G; Division of Infectious Disease, Wadsworth Center, New York State Department of Health, Albany, NY, USA., Doering J; Division of Infectious Disease, Wadsworth Center, New York State Department of Health, Albany, NY, USA., Berman K; Division of Infectious Disease, Wadsworth Center, New York State Department of Health, Albany, NY, USA., Richardson C; Technical Operations, Icosavax, Seattle, WA, USA., Lien H; Quality, Icosavax, Seattle, WA, USA., Kleanthous H; Discovery & Translational Sciences, Global Health, Bill and Melinda Gates Foundation, Seattle, WA, USA., Mantis NJ; Division of Infectious Disease, Wadsworth Center, New York State Department of Health, Albany, NY, USA., Joshi SB; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, USA., Volkin DB; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS, USA.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2023 Aug; Vol. 19 (2), pp. 2264594. Date of Electronic Publication: 2023 Nov 06.
Autor:
Bajoria S; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center (VAFC), University of Kansas, Lawrence, KS 66047, USA., Antunez LR; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center (VAFC), University of Kansas, Lawrence, KS 66047, USA., Kumru OS; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center (VAFC), University of Kansas, Lawrence, KS 66047, USA., Klempner M; MassBiologics of the University of Massachusetts Chan Medical School, Boston, MA 02126, USA., Wang Y; MassBiologics of the University of Massachusetts Chan Medical School, Boston, MA 02126, USA., Cavacini LA; MassBiologics of the University of Massachusetts Chan Medical School, Boston, MA 02126, USA., Joshi SB; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center (VAFC), University of Kansas, Lawrence, KS 66047, USA., Volkin DB; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center (VAFC), University of Kansas, Lawrence, KS 66047, USA. Electronic address: volkin@ku.edu.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2023 Jul; Vol. 112 (7), pp. 1832-1844. Date of Electronic Publication: 2023 Apr 10.
Autor:
Kumar P; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS 66047, USA., Wang M; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS 66047, USA., Kumru OS; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS 66047, USA., Hickey JM; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS 66047, USA., Sanmiguel J; Grousbeck Gene Therapy Center, Mass Eye and Ear, Harvard Medical School, Boston, MA 02114, USA., Zabaleta N; Grousbeck Gene Therapy Center, Mass Eye and Ear, Harvard Medical School, Boston, MA 02114, USA., Vandenberghe LH; Grousbeck Gene Therapy Center, Mass Eye and Ear, Harvard Medical School, Boston, MA 02114, USA., Joshi SB; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS 66047, USA., Volkin DB; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS 66047, USA.
Publikováno v:
Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2023 Jun 12; Vol. 30, pp. 103-121. Date of Electronic Publication: 2023 Jun 12 (Print Publication: 2023).
Autor:
Bajoria S; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS 66047, USA., Kumru OS; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS 66047, USA., Doering J; Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, NY 12208, USA., Berman K; Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, NY 12208, USA., Slyke GV; Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, NY 12208, USA., Prigodich A; Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, NY 12208, USA., Rodriguez-Aponte SA; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; The Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Kleanthous H; Bill & Melinda Gates Foundation, Seattle, WA 98109, USA., Love JC; The Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139, USA., Mantis NJ; Division of Infectious Diseases, Wadsworth Center, New York State Department of Health, Albany, NY 12208, USA., Joshi SB; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS 66047, USA., Volkin DB; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS 66047, USA.
Publikováno v:
Vaccines [Vaccines (Basel)] 2023 May 26; Vol. 11 (6). Date of Electronic Publication: 2023 May 26.
Autor:
Weidenbacher PA; Sarafan ChEM-H, Stanford University, Stanford, CA, USA.; Department of Chemistry, Stanford University, Stanford, CA, USA., Sanyal M; Sarafan ChEM-H, Stanford University, Stanford, CA, USA.; Department of Biochemistry, School of Medicine, Stanford University, Stanford, CA, USA., Friedland N; Sarafan ChEM-H, Stanford University, Stanford, CA, USA.; Department of Biochemistry, School of Medicine, Stanford University, Stanford, CA, USA., Tang S; Sarafan ChEM-H, Stanford University, Stanford, CA, USA.; Department of Biochemistry, School of Medicine, Stanford University, Stanford, CA, USA., Arunachalam PS; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA., Hu M; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA., Kumru OS; Vaccine Analytics and Formulation Center, Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, USA., Morris MK; California Department of Public Health, Richmond, CA, USA., Fontenot J; New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA, USA., Shirreff L; New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA, USA., Do J; Sarafan ChEM-H, Stanford University, Stanford, CA, USA.; Department of Biochemistry, School of Medicine, Stanford University, Stanford, CA, USA., Cheng YC; Sarafan ChEM-H, Stanford University, Stanford, CA, USA.; Department of Biochemistry, School of Medicine, Stanford University, Stanford, CA, USA., Vasudevan G; IAVI, New York, NY, USA., Feinberg MB; IAVI, New York, NY, USA., Villinger FJ; New Iberia Research Center, University of Louisiana at Lafayette, New Iberia, LA, USA., Hanson C; California Department of Public Health, Richmond, CA, USA., Joshi SB; Vaccine Analytics and Formulation Center, Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, USA., Volkin DB; Vaccine Analytics and Formulation Center, Department of Pharmaceutical Chemistry, University of Kansas, Lawrence, KS, USA., Pulendran B; Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, CA, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA., Kim PS; Sarafan ChEM-H, Stanford University, Stanford, CA, USA. kimpeter@stanford.edu.; Department of Biochemistry, School of Medicine, Stanford University, Stanford, CA, USA. kimpeter@stanford.edu.; Chan Zuckerberg Biohub, San Francisco, CA, 94158, USA. kimpeter@stanford.edu.
Publikováno v:
Nature communications [Nat Commun] 2023 Apr 17; Vol. 14 (1), pp. 2149. Date of Electronic Publication: 2023 Apr 17.
Autor:
Kumru OS; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS 66047, USA., Sanyal M; Department of Biochemistry, Stanford University School of Medicine, Palo Alto, CA, 94305 USA.; Sarafan ChEM-H, Stanford University, Stanford, CA, 94305, USA., Friedland N; Department of Biochemistry, Stanford University School of Medicine, Palo Alto, CA, 94305 USA.; Sarafan ChEM-H, Stanford University, Stanford, CA, 94305, USA., Hickey J; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS 66047, USA., Joshi R; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS 66047, USA., Weidenbacher P; Department of Biochemistry, Stanford University School of Medicine, Palo Alto, CA, 94305 USA.; Sarafan ChEM-H, Stanford University, Stanford, CA, 94305, USA., Do J; Department of Biochemistry, Stanford University School of Medicine, Palo Alto, CA, 94305 USA.; Sarafan ChEM-H, Stanford University, Stanford, CA, 94305, USA., Cheng YC; Department of Biochemistry, Stanford University School of Medicine, Palo Alto, CA, 94305 USA.; Sarafan ChEM-H, Stanford University, Stanford, CA, 94305, USA., Kim PS; Department of Biochemistry, Stanford University School of Medicine, Palo Alto, CA, 94305 USA.; Sarafan ChEM-H, Stanford University, Stanford, CA, 94305, USA.; Chan Zuckerberg Biohub, San Francisco, CA 94158, USA., Joshi SB; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS 66047, USA., Volkin DB; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, Lawrence, KS 66047, USA.
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2023 Apr 04. Date of Electronic Publication: 2023 Apr 04.
Autor:
Sharma N; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, 2030 Becker Drive, Lawrence, KS 66047, USA., Jerajani K; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, 2030 Becker Drive, Lawrence, KS 66047, USA., Wan Y; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, 2030 Becker Drive, Lawrence, KS 66047, USA., Kumru OS; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, 2030 Becker Drive, Lawrence, KS 66047, USA., Pullagurla SR; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, 2030 Becker Drive, Lawrence, KS 66047, USA., Ogun O; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, 2030 Becker Drive, Lawrence, KS 66047, USA., Mapari S; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, 2030 Becker Drive, Lawrence, KS 66047, USA., Brendle S; Department of Pathology, Pennsylvania State University College of Medicine, 500 University Drive, Hershey, Pennsylvania 17033, USA., Christensen ND; Department of Pathology, Pennsylvania State University College of Medicine, 500 University Drive, Hershey, Pennsylvania 17033, USA., Batwal S; Serum Institute of India Pvt. Ltd., Pune, India., Mahedvi M; Serum Institute of India Pvt. Ltd., Pune, India., Rao H; Serum Institute of India Pvt. Ltd., Pune, India., Dogar V; Serum Institute of India Pvt. Ltd., Pune, India., Chandrasekharan R; Serum Institute of India Pvt. Ltd., Pune, India., Shaligram U; Serum Institute of India Pvt. Ltd., Pune, India., Volkin DB; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, 2030 Becker Drive, Lawrence, KS 66047, USA. Electronic address: volkin@ku.edu., Joshi SB; Department of Pharmaceutical Chemistry, Vaccine Analytics and Formulation Center, University of Kansas, 2030 Becker Drive, Lawrence, KS 66047, USA. Electronic address: joshi@ku.edu.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2023 Feb; Vol. 112 (2), pp. 458-470. Date of Electronic Publication: 2022 Dec 01.